By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might be able to ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...
New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...
Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The ...
1don MSN
Why Ozempic's weight loss mechanism may finally give sleep apnea patients a new treatment path
Could Ozempic replace your CPAP? New research on GLP-1 drugs and sleep apnea has doctors paying attention.
New research shows Ozempic may reduce sleep apnea severity by over 50%. Here’s what the science actually says.
May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...
Today, Sunrise Group, a pioneer in medical device innovation and sleep care, announced that the new generation of its home sleep test, Sunrise Air, has officially received FDA clearance. This ...
Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, ...
Having both OSA and insomnia makes treatment more complex. Learn why addressing both is critical for heart health and how CBTi can help you stick to CPAP.
Sleep apnea affects approximately 1 out of 8 people worldwide, and people often remain in the dark about what’s going on.
ResMed (RMD) is in focus after announcing a collaboration with Oura that connects Oura Ring users in the US to ResMed’s sleep education tools, assessments, and potential care pathways for obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results